carvedilol has been researched along with Ovarian Neoplasms in 1 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoare, JI | 1 |
| Osmani, B | 1 |
| O'Sullivan, EA | 1 |
| Browne, A | 1 |
| Campbell, N | 1 |
| Metcalf, S | 1 |
| Nicolini, F | 1 |
| Saxena, J | 1 |
| Martin, SA | 1 |
| Lockley, M | 1 |
1 other study available for carvedilol and Ovarian Neoplasms
| Article | Year |
|---|---|
Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapy.
Topics: Adenoviridae; Adrenergic alpha-1 Receptor Antagonists; Animals; beta-Arrestins; Carvedilol; Cell Lin | 2022 |